We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type

7 results found


Nutter McClennen & Fish LLP | USA | 28 Mar 2012

Supreme Court remands Myriad for reconsideration in light of Mayo

Following close on the heels of last week’s controversial decision in Mayo Collaborative Services v. Prometheus Laboratories, the United States Supreme Court sent another hotly contested biotech case back down for further consideration by a lower federal court.


Nutter McClennen & Fish LLP | USA | 17 May 2010

Ground-breaking federal district court ruling on gene patents

In Association for Molecular Pathology et al. v. United States Patent And Trademark Office et al., Association for Molecular Pathology and other plaintiffs, including some physicians and cancer patients, asked a federal district court in New York, in a motion for summary judgment, to invalidate several so-called “gene patents” owned by the University of Utah and Myriad Genetics.

Previous page 1 Next page